Tag Archives: warfarin

Apixaban reduces stroke rates in atrial fibrillation patients with previous stroke or TIA

In a subset of patients that had experienced a previous stroke or transient ischemic attack (TIA), treatment with the investigational drug apixaban resulted in a reduced rate of stroke and systemic embolism compared with warfarin, according to a recent subset analysis of a major clinical trial. Stroke is the third-leading… 

Read more »
Posted in Cardiovascular, Neurology, Neurology Featured 2, Primary Care | Also tagged , , , , , , , , , , , , | Volume: | Leave a comment

Oral medication regimen for pulmonary embolism effective at preventing venous thromboembolism, causes fewer major bleeds

mdCurrent Conference Report: American College of Cardiology’s 61st Annual Scientific Session & Expo A new study looking at an all-oral medication regimen for treating pulmonary embolism (PE) finds it as effective as starting with injectable enoxaparin and then switching to warfarin. The one-agent regimen would permit most of the treatment… 

Read more »
Posted in Cardiology, Cardiovascular Disease, Pharmacology | Also tagged , , , , , , , , , , , , | Volume: | Leave a comment

Warfarin no better than aspirin in patients with heart failure

mdCurrent Conference Report: International Stroke Conference Warfarin did not reduce the rate of the combined endpoint of death, ischemic stroke, or intracerebral hemorrhage compared with aspirin, according to a Late Breaking Clinical Trial presented at the 2012 International Stroke Conference. Both warfarin and aspirin are used in this clinical setting,… 

Read more »
Posted in Cardiology, Cardiovascular, Cardiovascular Disease, Neurology, Non-Communicable Disease, Pharmacology, Primary Care | Also tagged , , , , , , , , , , , | Volume: | Leave a comment